Lung Cancer Clinical Trial Matching Service
As part of the Lung Cancer Clinical Trials Call to Action Campaign , Lung Cancer Alliance, National Lung Cancer Partnership, and other advocacy groups have partnered with EmergingMed to offer a personalized service for lung cancer patients “to take charge of their diagnosis and learn about clinical trials, which are an important part of treatment innovation.”
The initiative matches lung cancer patients with currently recruiting clinical trials based on the patient’s diagnosis. After building a profile covering areas such as activity level, level of cancer metastasis, type of cancer such as mesothelioma, treatment regimen, and other conditions, the patient is presented with a list of clinical trials for consideration.
The campaign partners recommend that patients search for clinical trial options prior to the start of their treatment and again when faced with new treatment decisions.
EmergingMed was founded in 2000 with a goal “to increase clinical trial awareness and access through one-on-one, personalized services provided through collaborations with a growing partner network.”
